| 产品编号 | CFN60054 | |
| CAS编号 | 877399-52-5 | |
| 分子式 = 分子量 | C21H22Cl2FN5O = 450.34 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 克唑替尼 | CFN60054 | 877399-52-5 | 1mg | QQ客服:2159513211 |
| 克唑替尼 | CFN60054 | 877399-52-5 | 5mg | QQ客服:2159513211 |
| 克唑替尼 | CFN60054 | 877399-52-5 | 10mg | QQ客服:2159513211 |
| 克唑替尼 | CFN60054 | 877399-52-5 | 20mg | QQ客服:2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Crizotinib (PF-02341066) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM in cell-based assays, respectively. It is also a potent ROS1 inhibitor with Ki value less than 0.025 nM. Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. |
| Targets: | c-Met | ALK | ROS1 | Autophagy | STAT3 |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.2205 mL | 11.1027 mL | 22.2054 mL | 44.4109 mL | 55.5136 mL |
| 5 mM | 0.4441 mL | 2.2205 mL | 4.4411 mL | 8.8822 mL | 11.1027 mL |
| 10 mM | 0.2221 mL | 1.1103 mL | 2.2205 mL | 4.4411 mL | 5.5514 mL |
| 50 mM | 0.0444 mL | 0.2221 mL | 0.4441 mL | 0.8882 mL | 1.1103 mL |
| 100 mM | 0.0222 mL | 0.111 mL | 0.2221 mL | 0.4441 mL | 0.5551 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 麦芽六糖; Maltohexaose | CFN90872 | 34620-77-4 | C36H62O31 = 990.9 | 20mg | QQ客服:3257982914 |
| 竹节参皂苷IVa; Chikusetsusaponin IVa | CFN92516 | 51415-02-2 | C42H66O14 = 795.0 | 20mg | QQ客服:1413575084 |
| Maingayone; Maingayone | CFN95479 | 271585-66-1 | C42H52O9 = 700.9 | 10mg | QQ客服:3257982914 |
| Gambogic acid A; Gambogic acid A | CFN95458 | 1592842-93-7 | C39H48O10 = 676.8 | 5mg | QQ客服:2056216494 |